Navigation Links
The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management

WESTBURY, N.Y., Aug. 25 /PRNewswire/ -- "Weight management is serious business. National health authorities are concerned that more than half of Americans are over weight, and for many obesity is not merely a matter of looking unattractive. It is a health hazard. Then why leave it to amateurs -- faddists, diet marketers, and celebrity promoters of the latest 'food system'?"

Dr. Frederic J. Vagnini, a nationally-known anti-aging and bariatric physician specializing in cardiovascular disease, weight management, and diabetes, introduces his metabolic diagnosis and weight management system.

The first phase of the metabolic diagnosis and weight management system (MD/WM) consists of three tests to determine multiple parameters of energy metabolism.

(1) A segmental body composition test measures lean body mass, total body

water, and percent of body fat.

(2) The calorimetry determines the body's basal metabolic rate or resting

energy expenditure and locates a weight management zone.

(3) The patient wears a multisensor arm band 5-10 days at home to

measure four key energy parameters: skin temperature, galvanic skin

response, heat flux, and motion.

The result of this 3-step test is a reading of total energy expenditure per day/per week, of calories burnt, plus physical activity levels (METs), and amount of sleep and steps taken.

In the second phase of the system, based on this scientific diagnosis, Dr. Vagnini sets up an individualized comprehensive weight management program for each patient.

Diabetes Prevention

The weight management program includes an initial cardiovascular workup, comprehensive thyroid, food allergy assessment and detoxification. According to government health statistics there are 40 to 60 million pre-diabetics in the country today for whom a comprehensive scientific weight management program can prevent the onset of full blown diabetes.

The treatment program follow-through includes partial meal replacement, fresh home food delivery services, and frequent medical nutritionist consultations with the use of nutraceuticals.

Finally, there are programs that use pharmacologic therapy, including appetite suppressants, insulin sensitizers, and new injectable weight management therapies.

For further information about the metabolic diagnosis and weight management system and the diabetes prevention program, contact Dr. Vagnini directly at (516) 369-2040.

SOURCE The Heart, Diabetes, and Weight Loss Centers of New York
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
2. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
3. New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People
4. New Data Confirm That Use of Levemir Can Limit Weight Gain
5. Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo
6. Weight Management is Not Enough for Cannabinoid Type 1 (CB1) Receptor Antagonists to Become a Commercial Success
7. Annual Meeting of the Consortium of Multiple Sclerosis Centers Focuses on the Challenges of Care and Research in Multiple Sclerosis
8. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
9. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
10. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
11. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
Post Your Comments:
(Date:10/12/2015)... New York , October 12, 2015 ... (FMI) delivers key insights on the global vital signs monitoring ... Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025." The ... at a healthy CAGR of 9.5% and 9.2% in terms ... to factors, regarding which FMI offers major insights in detail ...
(Date:10/12/2015)... Oct. 12, 2015 Beginning October 1, 2015 ... Partner, the fastest growing practice management system for therapists, ... easily converts all patient diagnostic codes from the former ... --> --> Therapy Partner has ... mental health practitioners to easily understand the conversion to ...
(Date:10/12/2015)... , Oct. 12, 2015 Indivior PLC (LON: INDV) ... of Delaware granted the Company,s motion ... Abbreviated New Drug Application (ANDA) No. 205299 to market a ... and naloxone) Sublingual Film (CIII) in the United ... Since August 2013, Indivior has received Paragraph IV certifications ...
Breaking Medicine Technology:
(Date:10/12/2015)... ... October 12, 2015 , ... To help ... its charitable donation to the National Breast Cancer Foundation. The National Breast Cancer ... breast cancer through early detection, education, and support services. , The annual campaign ...
(Date:10/12/2015)... ... October 12, 2015 , ... SQM Group ... a contact channel benchmarking study. Be a part of this insightful ... for improving customer experience, customer journey, contact channel execution and intelligence, workforce optimization, ...
(Date:10/12/2015)... ... ... Holcomb – Kreithen Plastic Surgery and MedSpa, PLLC (“Holcomb – Kreithen”), one of ... Surgery University,” an educational series of mini seminars covering aesthetic and plastic surgery options, ... Saturday, October 24, 2015. , The goal of the event is to provide hands-on ...
(Date:10/12/2015)... ... October 12, 2015 , ... The Asthma and ... Engagement Award by the Patient-Centered Outcomes Research Institute (PCORI) for a new project ... , The project, entitled “Training Patients with Asthma to Understand and Participate in ...
(Date:10/12/2015)... ... October 12, 2015 , ... International law firm Greenberg ... with the U.S. Biomedical Advanced Research and Development Authority (BARDA) reported to be ... ReCell® Autologous Cell Harvesting Device under a U.S. mass casualty preparedness program. ...
Breaking Medicine News(10 mins):